The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Net Asset Value(s)

3 Apr 2017 11:53

RNS Number : 3820B
Intl. Biotechnology Trust PLC
03 April 2017
 

 

 

International Biotechnology Trust plc

Net Asset Values

 

The Board of International Biotechnology Trust plc announces that the unaudited net asset value per share

 

 

Date

NAV

Pence

Friday 31 Mar

Ex Income

647.80

Friday 31 Mar

Cum Income

644.94

 

 

The above disclosure on NAV categorisation is as per the AIC guidance note "NAVs published via Regulatory Information Service (RIS) Platforms" issued 3 July 2007

 

 

 

03-Apr-2017

 

 

 

 

Enquiries:

International Biotechnology Trust plc

 

Nick Coleman

SV Life Sciences Managers LLP

020 7421 7070

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVUGUPACUPMGUW

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.